Experts: Cancer drugs remain in short supply, delaying life-saving treatment
At an American Cancer Society meeting, doctors said 75% of pediatric oncology centers in the U.S. don't have enough Methotrexate.
•
Sep 27, 2023, 2:09 PM
•
Updated 303 days ago
Share:
More Stories
1:30
Officials: Calls to 988 have increased since its creation 2 years ago
5ds ago1:41
Officials: COVID-19 has hit high levels in several states, including Connecticut
6ds ago2:03
Poll: More than 40% of women skip or delay medical screenings and appointments
12ds ago1:59
New Alzheimer's drug shown to reduce memory loss for some patients
19ds ago1:59
Study: Eating ultra-processed foods can shorten your lifespan
20ds ago1:29
Staying hydrated – what to drink depends on your level of physical activity, doctor says
26ds ago1:30
Officials: Calls to 988 have increased since its creation 2 years ago
5ds ago1:41
Officials: COVID-19 has hit high levels in several states, including Connecticut
6ds ago2:03
Poll: More than 40% of women skip or delay medical screenings and appointments
12ds ago1:59
New Alzheimer's drug shown to reduce memory loss for some patients
19ds ago1:59
Study: Eating ultra-processed foods can shorten your lifespan
20ds ago1:29
Staying hydrated – what to drink depends on your level of physical activity, doctor says
26ds agoExperts say cancer drugs remain in short supply, delaying life-saving treatment.
At an American Cancer Society meeting, doctors said 75% of pediatric oncology centers in the U.S. don't have enough Methotrexate.
The chemotherapy drug is used to treat a wide variety of childhood cancers.
Analysts say most of the drugs in short supply do not make a profit, so companies are reluctant to make them.
